Cargando…
Molecular Docking studies of D2 Dopamine receptor with Risperidone derivatives
In this work, 3D model of D2 dopamine receptor was determined by comparative homology modeling program MODELLER. The computed model's energy was minimized and validated using PROCHECK and Errat tool to obtain a stable model structure and was submitted in Protein Model Database (PMDB-ID: PM00792...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916812/ https://www.ncbi.nlm.nih.gov/pubmed/24516319 http://dx.doi.org/10.6026/97320630010008 |
_version_ | 1782302765047873536 |
---|---|
author | Bhargava, Kiran Nath, Rajendra Seth, Prahlad Kumar Pant, Kamlesh Kumar Dixit, Rakesh Kumar |
author_facet | Bhargava, Kiran Nath, Rajendra Seth, Prahlad Kumar Pant, Kamlesh Kumar Dixit, Rakesh Kumar |
author_sort | Bhargava, Kiran |
collection | PubMed |
description | In this work, 3D model of D2 dopamine receptor was determined by comparative homology modeling program MODELLER. The computed model's energy was minimized and validated using PROCHECK and Errat tool to obtain a stable model structure and was submitted in Protein Model Database (PMDB-ID: PM0079251). Stable model was used for molecular docking against Risperidone and their 15 derivatives using AutoDock 4.2, which resulted in energy-based descriptors such as Binding Energy, Ligand Efficiency, Inhib Constant, Intermol energy, vdW + Hbond + desolv Energy, Electrostatic Energy, Total Internal Energy and Torsional Energy. After that, we have built quantitative structure activity relationship (QSAR) model, which was trained and tested on Risperidone and their 15 derivatives having activity value pKi in µM. For QSAR modeling, Multiple Linear Regression model was engendered using energy-based descriptors yielding correlation coefficient r2 of 0.513. To assess the predictive performance of QSAR models, different cross-validation procedures were adopted. Our results suggests that ligand-receptor binding interactions for D2 employing QSAR modeling seems to be a promising approach for prediction of pKi value of novel antagonists against D2 receptor. |
format | Online Article Text |
id | pubmed-3916812 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Biomedical Informatics |
record_format | MEDLINE/PubMed |
spelling | pubmed-39168122014-02-10 Molecular Docking studies of D2 Dopamine receptor with Risperidone derivatives Bhargava, Kiran Nath, Rajendra Seth, Prahlad Kumar Pant, Kamlesh Kumar Dixit, Rakesh Kumar Bioinformation Hypothesis In this work, 3D model of D2 dopamine receptor was determined by comparative homology modeling program MODELLER. The computed model's energy was minimized and validated using PROCHECK and Errat tool to obtain a stable model structure and was submitted in Protein Model Database (PMDB-ID: PM0079251). Stable model was used for molecular docking against Risperidone and their 15 derivatives using AutoDock 4.2, which resulted in energy-based descriptors such as Binding Energy, Ligand Efficiency, Inhib Constant, Intermol energy, vdW + Hbond + desolv Energy, Electrostatic Energy, Total Internal Energy and Torsional Energy. After that, we have built quantitative structure activity relationship (QSAR) model, which was trained and tested on Risperidone and their 15 derivatives having activity value pKi in µM. For QSAR modeling, Multiple Linear Regression model was engendered using energy-based descriptors yielding correlation coefficient r2 of 0.513. To assess the predictive performance of QSAR models, different cross-validation procedures were adopted. Our results suggests that ligand-receptor binding interactions for D2 employing QSAR modeling seems to be a promising approach for prediction of pKi value of novel antagonists against D2 receptor. Biomedical Informatics 2014-01-29 /pmc/articles/PMC3916812/ /pubmed/24516319 http://dx.doi.org/10.6026/97320630010008 Text en © 2014 Biomedical Informatics This is an open-access article, which permits unrestricted use, distribution, and reproduction in any medium, for non-commercial purposes, provided the original author and source are credited. |
spellingShingle | Hypothesis Bhargava, Kiran Nath, Rajendra Seth, Prahlad Kumar Pant, Kamlesh Kumar Dixit, Rakesh Kumar Molecular Docking studies of D2 Dopamine receptor with Risperidone derivatives |
title | Molecular Docking studies of D2 Dopamine receptor with Risperidone derivatives |
title_full | Molecular Docking studies of D2 Dopamine receptor with Risperidone derivatives |
title_fullStr | Molecular Docking studies of D2 Dopamine receptor with Risperidone derivatives |
title_full_unstemmed | Molecular Docking studies of D2 Dopamine receptor with Risperidone derivatives |
title_short | Molecular Docking studies of D2 Dopamine receptor with Risperidone derivatives |
title_sort | molecular docking studies of d2 dopamine receptor with risperidone derivatives |
topic | Hypothesis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916812/ https://www.ncbi.nlm.nih.gov/pubmed/24516319 http://dx.doi.org/10.6026/97320630010008 |
work_keys_str_mv | AT bhargavakiran moleculardockingstudiesofd2dopaminereceptorwithrisperidonederivatives AT nathrajendra moleculardockingstudiesofd2dopaminereceptorwithrisperidonederivatives AT sethprahladkumar moleculardockingstudiesofd2dopaminereceptorwithrisperidonederivatives AT pantkamleshkumar moleculardockingstudiesofd2dopaminereceptorwithrisperidonederivatives AT dixitrakeshkumar moleculardockingstudiesofd2dopaminereceptorwithrisperidonederivatives |